We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$189M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$143M
3
MRK icon
Merck
MRK
+$136M
4
ABMD
Abiomed Inc
ABMD
+$124M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$124M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CORT icon
1776
Corcept Therapeutics
CORT
$10.2B
– –
-1,146
Closed -$73K
COTY icon
1777
Coty
COTY
$2.33B
– –
-2,800
Closed -$40K
CPRX
1778
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-186,900
Closed -$2.42M
CRC icon
1779
California Resources
CRC
$4.75B
– –
-1,700
Closed -$88K
CRI icon
1780
Carter's
CRI
$1.43B
– –
-452
Closed -$42K
CRK icon
1781
Comstock Resources
CRK
$3.97B
– –
-5,196
Closed -$111K
CRNC icon
1782
Cerence
CRNC
$382M
– –
-400
Closed -$13K
CRNX icon
1783
Crinetics Pharmaceuticals
CRNX
$8.86B
– –
-3,138
Closed -$62K
CRVL icon
1784
CorVel
CRVL
$3.05B
– –
-1,329
Closed -$77K
CSTL icon
1785
Castle Biosciences
CSTL
$749M
– –
-850
Closed -$35K
CSW
1786
CSW Industrials
CSW
$4.71B
– –
-464
Closed -$66K
CTLP
1787
DELISTED
Cantaloupe
CTLP
– –
-6,318
Closed -$22K
CVBF icon
1788
CVB Financial
CVBF
$3.98B
– –
-1,404
Closed -$58K
CVCO icon
1789
Cavco Industries
CVCO
$4.39B
– –
-87
Closed -$45K
CVLT icon
1790
Commault Systems
CVLT
$5.89B
– –
-1,050
Closed -$68K
CW icon
1791
Curtiss-Wright
CW
$27.7B
– –
-663
Closed -$153K
CYH icon
1792
Community Health Systems
CYH
$385M
– –
-4,278
Closed -$10K
DDD icon
1793
3D Systems Corp
DDD
$420M
– –
-1,389
Closed -$25K
DHIL
1794
DELISTED
Diamond Hill
DHIL
– –
-1,685
Closed -$291K
DIN icon
1795
Dine Brands
DIN
$432M
– –
-877
Closed -$67K
DNLI icon
1796
Denali Therapeutics
DNLI
$3.67B
– –
-832
Closed -$72K
DNOW icon
1797
DNOW Inc
DNOW
$2.63B
– –
-6,075
Closed -$81K
DOCN icon
1798
DigitalOcean
DOCN
$14.4B
– –
-1,180
Closed -$63K
DOMO icon
1799
Domo
DOMO
$166M
– –
-457,239
Closed -$8.23M
DORM icon
1800
Dorman Products
DORM
$4.01B
– –
-291
Closed -$64K
70 71
72
73 74

Similar funds

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.